Key F Inancial Inc Abb Vie Inc. Transaction History

Key F Inancial Inc

$446 Million
Q3 2024

A detailed history of Key F Inancial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 15,300 shares of ABBV stock, worth $2.7 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

15,300

Previous 15,269 0.2%

Holding current value

$2.7 Million

Previous $2.62 Million 15.39%

% of portfolio

0.68%

Previous 0.64%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$163.84 - $199.33 $5,079 - $6,179	31 Added 0.2%	15,300 $3.02 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $23,837 - $27,837	154 Added 1.02%	15,269 $2.62 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $51,781 - $59,000	324 Added 2.19%	15,115 $2.75 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $2,064 - $2,324	15 Added 0.1%	14,791 $2.29 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $1,736 - $2,010	13 Added 0.09%	14,776 $2.2 Million
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $84,541 - $105,206	638 Added 4.52%	14,763 $1.99 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $317,274 - $365,388	2,194 Added 18.39%	14,125 $2.25 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $731,041 - $838,456	5,447 Added 84.01%	11,931 $1.6 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $10,459 - $13,296	76 Added 1.19%	6,484 $997,000
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $55,563 - $68,938	421 Added 7.03%	6,408 $1.04 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $1,181 - $1,495	11 Added 0.18%	5,987 $811,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $11,678 - $13,010	111 Added 1.89%	5,976 $695,000
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $16,368 - $18,019	160 Added 2.8%	5,865 $635,000
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $8,048 - $10,867	-100 Reduced 1.72%	5,705 $611,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $8,591 - $10,083	100 Added 1.75%	5,805 $508,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $18,782 - $25,134	256 Added 4.7%	5,705 $550,000
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $29,025 - $44,005	-450 Reduced 7.63%	5,449 $410,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $425,494 - $532,384	5,899 New	5,899 $522,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.

Account

Key F Inancial Inc Abb Vie Inc. Transaction History